SavedAdd your journal

Journals / Annals of Medical Research / 2022 / Cilt: 29 - Sayı: 4

Investigation of the potential beneficial effects of fish oil against methotrexate-induced brain injury

Kürşat KAYA
Ali GÜLER
Volkan İPEK
Pages
391–396
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our results support that the use of FO may benefit against neurological oxidative damage caused by MTX.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Methotrexate (MTX), a folic acid antagonist, is widely used in the treatment of many malignancies.
📊
Key Findings & Data:Materials and Methods: Twenty-eight rats were randomly divided into 4 groups (n = 7).
💡
Conclusion & Impact:Conclusion: Our results support that the use of FO may benefit against neurological oxidative damage caused by MTX.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Methotrexate (MTX), a folic acid antagonist, is widely used in the treatment of many malignancies. However, various serious side effects caused by MTX limit its clinical use. Neurotoxicity is one of the most important side effects seen during MTX treatment. Oxidative damage is explained as one of the side-effect mechanisms caused by MTX. In addition to the many health benefits of fish oil (FO), its antioxidant properties have also been shown in various studies. In this study, it was aimed to investigate the potential beneficial effects of FO against oxidative brain damage caused by MTX. Materials and Methods: Twenty-eight rats were randomly divided into 4 groups (n = 7). The first group is the control group. The second group was determined as the FO group and 1000 mg / kg / day FO was given by gavage to the rats in this group for two weeks. The third group was determined as MTX group and a single dose of 20 mg / kg MTX was injected intraperitoneally to the rats in this group on the third day. The fourth group was determined as MTX + FO group, and the rats in the group were given MTX and FO in similar doses together. Results: The administration of MTX caused significant increase in TBARS levels compared to the control group, and significant decrease in SOD, GPx and CAT activities. However, the administration of FO with MTX caused statistically significant decrease in TBARS level and a significant increase in SOD and GPx activities compared to MTX group. On the other hand, there was no difference between the groups in terms of GSH levels. In addition, administration of MTX did not cause a histopathologically significant lesion in the brain tissue. Conclusion: Our results support that the use of FO may benefit against neurological oxidative damage caused by MTX.

🔖

Cite This Article

KAYA, K., GÜLER, A., İPEK, V. (2022). Investigation of the potential beneficial effects of fish oil against methotrexate-induced brain injury. Annals of Medical Research, Cilt: 29 - Sayı: 4, 391–396. https://ajindex.com/articles/445642

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Hirako A, Furukawa S, Takeuchi T, Sugiyama A. Effect of methotrexate exposure at late gestation on development of telencephalon in rat fetal brain. J Vet Med Sci. 2016;78(2):213–20
  2. Howard SC, McCormick J, Pui C, et al. Preventing and managing toxicities of high-dose methotrexate. Oncologist 2016;21(12):1471–82
  3. Hafez HM, Ibrahim MA, Ibrahim SA, et al. Potential protective effect of etanercept and aminoguanidine in methotrexateinduced hepatotoxicity and nephrotoxicity in rats. Eur J Pharmacol 2015;768:1–12
  4. Sun J, Sugiyama A, Inoue S, et al. Effect of methotrexate on neuroepithelium in the rat fetal brain. J Vet Med Sci 2014;76(3):347–54
  5. Campbell JM, Bateman E, Peters MDJ, et al. Fluoropyrimidine and platinum toxicity pharmacogenetics: An umbrella review of systematic reviews and meta-analyses. Pharmacogenomics 2016;17(4):435–51
  6. Bernsen EC, Hagleitner MM, Kouwenberg TW, et al. Pharmacogenomics as a tool to limit acute and long-term adverse effects of chemotherapeutics: An update in pediatric oncology. Front Pharmacol 2020;11:1–19
  7. Şener G, Ekşioğlu-Demiralp E, Çetiner M, et al. β-glucan ameliorates methotrexate-induced oxidative organ injury via its antioxidant and immunomodulatory effects. Eur J Pharmacol 2006;170–8
  8. Leite RA, Vosgrau JS, Cortez Neto L, et al. Brainstem auditory pathway of children with acute lymphoid leukemia on chemotherapy with methotrexate. Arq Neuropsiquiatr 2020;78(2):63–9
  9. Rollins N, Winick N, Bash R, et al. Acute methotrexate neurotoxicity: Findings on diffusion-weighted imaging and correlation with clinical outcome. Am J Neuroradiol 2004;25(10):1688–95
  10. Yang M, Kim JS, Kim J, et al. Acute treatment with methotrexate induces hippocampal dysfunction in a mouse model of breast cancer. Brain Res Bull 2012;89(1–2):50–6
  11. Vardi N, Parlakpinar H, Ates B. Beneficial effects of chlorogenic acid on methotrexate-induced cerebellar Purkinje cell damage in rats. J Chem Neuroanat 2012;43(1):43–7
  12. Elbarbary NS, Ismail EAR, Farahat RK, et al. ω-3 fatty acids as an adjuvant therapy ameliorates methotrexate-induced hepatotoxicity in children and adolescents with acute lymphoblastic leukemia: A randomized placebo-controlled study. Nutrition 2016;32(1):41–7
  13. Koppelmann T, Pollak Y, Mogilner J, et al. Reversal of severe methotrexate-induced intestinal damage using enteral n-3 fatty acids. Br J Nutr 2013;109(1):89–98
  14. Kamisli S, Ciftci O, Cetin A, et al. Fish oil protects the peripheral and c